181 related articles for article (PubMed ID: 34819374)
1. Colon cancer cells acquire immune regulatory molecules from tumor-infiltrating lymphocytes by trogocytosis.
Shin JH; Jeong J; Maher SE; Lee HW; Lim J; Bothwell ALM
Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34819374
[TBL] [Abstract][Full Text] [Related]
2. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
3. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J
J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes and Trogocytosis-Mediated Signaling.
Reed J; Reichelt M; Wetzel SA
Cells; 2021 Jun; 10(6):. PubMed ID: 34204661
[TBL] [Abstract][Full Text] [Related]
5. Trogocytosis of CD80 and CD86 by induced regulatory T cells.
Gu P; Gao JF; D'Souza CA; Kowalczyk A; Chou KY; Zhang L
Cell Mol Immunol; 2012 Mar; 9(2):136-46. PubMed ID: 22307040
[TBL] [Abstract][Full Text] [Related]
6. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
Taylor NA; Vick SC; Iglesia MD; Brickey WJ; Midkiff BR; McKinnon KP; Reisdorf S; Anders CK; Carey LA; Parker JS; Perou CM; Vincent BG; Serody JS
J Clin Invest; 2017 Sep; 127(9):3472-3483. PubMed ID: 28825599
[TBL] [Abstract][Full Text] [Related]
7. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.
Sanseviero E; O'Brien EM; Karras JR; Shabaneh TB; Aksoy BA; Xu W; Zheng C; Yin X; Xu X; Karakousis GC; Amaravadi RK; Nam B; Turk MJ; Hammerbacher J; Rubinstein MP; Schuchter LM; Mitchell TC; Liu Q; Stone EL
Cancer Immunol Res; 2019 Aug; 7(8):1371-1380. PubMed ID: 31239316
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of CCR4⁺CTLA-4 FOXP3⁺CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells.
Svensson H; Olofsson V; Lundin S; Yakkala C; Björck S; Börjesson L; Gustavsson B; Quiding-Järbrink M
PLoS One; 2012; 7(2):e30695. PubMed ID: 22319577
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
[TBL] [Abstract][Full Text] [Related]
10. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Simpson TR; Li F; Montalvo-Ortiz W; Sepulveda MA; Bergerhoff K; Arce F; Roddie C; Henry JY; Yagita H; Wolchok JD; Peggs KS; Ravetch JV; Allison JP; Quezada SA
J Exp Med; 2013 Aug; 210(9):1695-710. PubMed ID: 23897981
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice.
Hsu FT; Chen TC; Chuang HY; Chang YF; Hwang JJ
Oncotarget; 2015 Dec; 6(42):44134-50. PubMed ID: 26683520
[TBL] [Abstract][Full Text] [Related]
12. Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation.
Li SY; Liu Y; Xu CF; Shen S; Sun R; Du XJ; Xia JX; Zhu YH; Wang J
J Control Release; 2016 Jun; 231():17-28. PubMed ID: 26829099
[TBL] [Abstract][Full Text] [Related]
13. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
14. T cells at the site of autoimmune inflammation show increased potential for trogocytosis.
Haastert B; Mellanby RJ; Anderton SM; O'Connor RA
PLoS One; 2013; 8(12):e81404. PubMed ID: 24324692
[TBL] [Abstract][Full Text] [Related]
15. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
16. Gnawing Between Cells and Cells in the Immune System: Friend or Foe? A Review of Trogocytosis.
Zhao S; Zhang L; Xiang S; Hu Y; Wu Z; Shen J
Front Immunol; 2022; 13():791006. PubMed ID: 35185886
[TBL] [Abstract][Full Text] [Related]
17. Shaping of T Cell Functions by Trogocytosis.
Nakayama M; Hori A; Toyoura S; Yamaguchi SI
Cells; 2021 May; 10(5):. PubMed ID: 34068819
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells.
Keerthivasan S; Aghajani K; Dose M; Molinero L; Khan MW; Venkateswaran V; Weber C; Emmanuel AO; Sun T; Bentrem DJ; Mulcahy M; Keshavarzian A; Ramos EM; Blatner N; Khazaie K; Gounari F
Sci Transl Med; 2014 Feb; 6(225):225ra28. PubMed ID: 24574339
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
Yu P; Steel JC; Zhang M; Morris JC; Waitz R; Fasso M; Allison JP; Waldmann TA
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6187-92. PubMed ID: 22474386
[TBL] [Abstract][Full Text] [Related]
20. Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity.
Li KJ; Wu CH; Lu CH; Shen CY; Kuo YM; Tsai CY; Hsieh SC; Yu CL
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
